SynAct Pharma AB (“SynAct” or the “Company”) hereby announces that the Company’s shareholders TJ Biotech ApS (wholly-owned by the board member and CSO Thomas Jonassen) and Quantass ApS (owned by the CE...
Read more
Welcome to SynAct Pharma AB’s website. We use cookies to optimise your use of our website. A cookie is a text file that is stored on your computer. If you want further information about what a cookie is, what cookies we use, what the purpose of the cookie is or how you can block or delete cookies, please read “About cookies“. By continuing, you agree to our use of cookies.
Close
